Tau mediates the impact of amyloid and vascular disease burden on the trajectory of clinical symptoms

Longer amyloid (A) and vascular disease (V) chronicity were associated with faster cognitive decline, emphasizing the importance of considering chronic exposure to these pathologies. Individuals with higher V burden experienced a steeper decline in cognition in the presence of A pathology, highlighting the interaction between V and neurodegenerative processes. Progression from early to mild dementia was faster with greater white matter hyperintensity chronicity, even when A duration was held constant, supporting the idea that V pathology amplifies the clinical impact of amyloid in Alzheimer's disease. Tau accumulation played a significant mediating role in linking A and V burden to cognitive decline, suggesting that tau pathology is a critical downstream factor in symptom progression. Person-level chronicity estimates of A and V provide a more precise understanding of cognitive decline trajectories, offering insights for early intervention strategies.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-10-01
DOI
https://doi.org/10.1002/alz.70831
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tau mediates the impact of amyloid and vascular disease burden on the trajectory of clinical symptoms

Bruce P. Hermann, Tobey J. Betthauser, Bradley Christian, Rebecca L. Koscik et al.
Alzheimer s & Dementia
Dementia and Cognitive Impairment Research
article

Tau mediates the impact of amyloid and vascular disease burden on the trajectory of clinical symptoms

Bruce P. Hermann, Tobey J. Betthauser, Bradley Christian, Rebecca L. Koscik, Lianlian Du, Robert V. Cadman, Aaron S. Field, Erin M. Jonaitis, Karly Alex Cody, Leonardo A. Rivera‐Rivera, Laura B. Eisenmenger, Nathaniel A. Chin, Sterling C. Johnson, Kevin M. Johnson, Sanjay Asthana
article en

Abstract

Longer amyloid (A) and vascular disease (V) chronicity were associated with faster cognitive decline, emphasizing the importance of considering chronic exposure to these pathologies. Individuals with higher V burden experienced a steeper decline in cognition in the presence of A pathology, highlighting the interaction between V and neurodegenerative processes. Progression from early to mild dementia was faster with greater white matter hyperintensity chronicity, even when A duration was held constant, supporting the idea that V pathology amplifies the clinical impact of amyloid in Alzheimer's disease. Tau accumulation played a significant mediating role in linking A and V burden to cognitive decline, suggesting that tau pathology is a critical downstream factor in symptom progression. Person-level chronicity estimates of A and V provide a more precise understanding of cognitive decline trajectories, offering insights for early intervention strategies.

Alzheimer s & DementiaVol. 21(10)
Rush University Medical Center (US), University of Wisconsin–Madison (US), University of Wisconsin Health (US), Wisconsin Division of Public Health (US), Stanford University (US)
Openalex Percentile: Top 62%
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.